DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
65.49
+0.24 (0.37%)
At close: Dec 5, 2025, 4:00 PM EST
65.70
+0.21 (0.32%)
After-hours: Dec 5, 2025, 7:02 PM EST
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$438,437
Profits / Employee
$69,971
Market Cap
25.54B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DXCM News
- 1 day ago - HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 1 day ago - Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines - GlobeNewsWire
- 2 days ago - Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy - Business Wire
- 10 days ago - Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review - Seeking Alpha
- 10 days ago - Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors - Seeking Alpha
- 10 days ago - Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 11 days ago - GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program - Newsfile Corp
- 12 days ago - Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc. - PRNewsWire